Lyell Immunopharma LYEL
NASDAQ LYEL
$9.39 +0.01 (+0.11%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lyell Immunopharma (LYEL) Sale and Maturity of Investments (2020 - 2026)

Updated

Analysis

Lyell Immunopharma (LYEL) Sale and Maturity of Investments (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Lyell Immunopharma 219.70 Mn -805.27 Mn - 69.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69.39 Mn
Mar 31, 2026 54.65 Mn
Dec 31, 2025 52.91 Mn
Sep 30, 2025 74.14 Mn
Jun 30, 2025 93.52 Mn
Mar 31, 2025 154.12 Mn
Dec 31, 2024 123.70 Mn
Sep 30, 2024 133.41 Mn
Jun 30, 2024 161.80 Mn
Mar 31, 2024 130.04 Mn
Dec 31, 2023 156.12 Mn
Sep 30, 2023 178.15 Mn
Jun 30, 2023 187.10 Mn
Mar 31, 2023 142.25 Mn
Dec 31, 2022 110.90 Mn
Sep 30, 2022 106.50 Mn
Jun 30, 2022 121.85 Mn
Mar 31, 2022 79.81 Mn
Dec 31, 2021 70.33 Mn
Sep 30, 2021 142.04 Mn
API Access

Lyell Immunopharma Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=LYEL&period=max&api_key=YOUR_API_KEY